Shares of Halyard Health, Inc. (NYSE:HYH) reached a new 52-week high on Thursday . The stock traded as high as $45.72 and last traded at $45.71, with a volume of 132,709 shares trading hands. The stock had previously closed at $45.37.

Several research firms recently weighed in on HYH. BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 19th. Deutsche Bank AG raised their price objective on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research note on Wednesday, July 12th. Finally, TheStreet raised Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $42.25.

The stock has a market cap of $2.14 billion, a PE ratio of 44.07 and a beta of 1.76. The company’s 50 day moving average price is $42.57 and its 200 day moving average price is $39.44.

Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The firm had revenue of $399.20 million during the quarter, compared to analysts’ expectations of $399.16 million. During the same period in the prior year, the business earned $0.45 EPS. The company’s revenue for the quarter was down .2% compared to the same quarter last year. On average, equities research analysts anticipate that Halyard Health, Inc. will post $1.98 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of Halyard Health by 6,362.1% in the 1st quarter. BlackRock Inc. now owns 5,939,352 shares of the medical instruments supplier’s stock worth $226,229,000 after purchasing an additional 5,847,442 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Halyard Health by 4.7% in the 1st quarter. Vanguard Group Inc. now owns 4,350,518 shares of the medical instruments supplier’s stock worth $165,711,000 after purchasing an additional 196,367 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Halyard Health by 19.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,133,049 shares of the medical instruments supplier’s stock worth $123,067,000 after purchasing an additional 507,893 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Halyard Health by 242.8% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,864,646 shares of the medical instruments supplier’s stock worth $73,244,000 after purchasing an additional 1,320,735 shares in the last quarter. Finally, State Street Corp boosted its holdings in shares of Halyard Health by 7.5% in the 2nd quarter. State Street Corp now owns 1,702,423 shares of the medical instruments supplier’s stock worth $66,872,000 after purchasing an additional 119,154 shares in the last quarter. Hedge funds and other institutional investors own 91.02% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/08/halyard-health-inc-hyh-sets-new-52-week-high-at-45-72.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.